A Multistate Investigation of Serious Adverse Events, including Deaths, following Ceftriaxone Injections, September 2024-August 2025.

Pierce R, Agarwal R, Kayira D, Lovegrove MC, Stone ND, Hatfield KM, Lyles JL, Morrison M, Stubblefield W, Davidson SL, Landers K, Harris S, Bhattarai R, Dulski T, Stoltey J, Biehle L, Hoffner J, Charles A, Wagner J, Beeman H, Curran MJ, Lee G, Moore R, Walters J, Patel G, Tran D, Sinkevitch J, Tori M, Wilson C, Godwin S, Hussaini S, Lafferty AG, Bernard S, Ruelle S, Dasenbrock CO, Sheridan M, Wackes F, Kapoor R, Gopalaswamy R, Perkins KM, Adverse Event Investigation Group

Open source

DOI
10.1093/cid/ciag521
Published
2026 Sep 3
Container
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciag521,
  title = {A Multistate Investigation of Serious Adverse Events, including Deaths, following Ceftriaxone Injections, September 2024-August 2025.},
  author = {Pierce R and Agarwal R and Kayira D and Lovegrove MC and Stone ND and Hatfield KM and Lyles JL and Morrison M and Stubblefield W and Davidson SL and Landers K and Harris S and Bhattarai R and Dulski T and Stoltey J and Biehle L and Hoffner J and Charles A and Wagner J and Beeman H and Curran MJ and Lee G and Moore R and Walters J and Patel G and Tran D and Sinkevitch J and Tori M and Wilson C and Godwin S and Hussaini S and Lafferty AG and Bernard S and Ruelle S and Dasenbrock CO and Sheridan M and Wackes F and Kapoor R and Gopalaswamy R and Perkins KM and Adverse Event Investigation Group},
  year = {2026},
  journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  doi = {10.1093/cid/ciag521},
  url = {https://doi.org/10.1093/cid/ciag521}
}

RIS

TY  - JOUR
TI  - A Multistate Investigation of Serious Adverse Events, including Deaths, following Ceftriaxone Injections, September 2024-August 2025.
AU  - Pierce R
AU  - Agarwal R
AU  - Kayira D
AU  - Lovegrove MC
AU  - Stone ND
AU  - Hatfield KM
AU  - Lyles JL
AU  - Morrison M
AU  - Stubblefield W
AU  - Davidson SL
AU  - Landers K
AU  - Harris S
AU  - Bhattarai R
AU  - Dulski T
AU  - Stoltey J
AU  - Biehle L
AU  - Hoffner J
AU  - Charles A
AU  - Wagner J
AU  - Beeman H
AU  - Curran MJ
AU  - Lee G
AU  - Moore R
AU  - Walters J
AU  - Patel G
AU  - Tran D
AU  - Sinkevitch J
AU  - Tori M
AU  - Wilson C
AU  - Godwin S
AU  - Hussaini S
AU  - Lafferty AG
AU  - Bernard S
AU  - Ruelle S
AU  - Dasenbrock CO
AU  - Sheridan M
AU  - Wackes F
AU  - Kapoor R
AU  - Gopalaswamy R
AU  - Perkins KM
AU  - Adverse Event Investigation Group
PY  - 2026
JO  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
DO  - 10.1093/cid/ciag521
UR  - https://doi.org/10.1093/cid/ciag521
ER  - 

APA

R, P., R, A., D, K., MC, L., ND, S., KM, H., JL, L., M, M., W, S., SL, D., K, L., S, H., R, B., T, D., J, S., L, B., J, H., A, C., J, W., H, B., MJ, C., G, L., R, M., J, W., G, P., D, T., J, S., M, T., C, W., S, G., S, H., AG, L., S, B., S, R., CO, D., M, S., F, W., R, K., R, G., KM, P., & Group, A. E. I. (2026). A Multistate Investigation of Serious Adverse Events, including Deaths, following Ceftriaxone Injections, September 2024-August 2025.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciag521

Source records